Literature DB >> 32499437

Iridium-catalyzed acid-assisted asymmetric hydrogenation of oximes to hydroxylamines.

Josep Mas-Roselló1, Tomas Smejkal2, Nicolai Cramer3.   

Abstract

Asymmetric hydrogenations are among the most practical methods for the synthesis of chiral building blocks at industrial scale. The selective reduction of an oxime to the corresponding chiral hydroxylamine derivative remains a challenging variant because of undesired cleavage of the weak nitrogen-oxygen bond. We report a robust cyclometalated iridium(III) complex bearing a chiral cyclopentadienyl ligand as an efficient catalyst for this reaction operating under highly acidic conditions. Valuable N-alkoxy amines can be accessed at room temperature with nondetected overreduction of the N‒O bond. Catalyst turnover numbers up to 4000 and enantiomeric ratios up to 98:2 are observed. The findings serve as a blueprint for the development of metal-catalyzed enantioselective hydrogenations of challenging substrates.
Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Year:  2020        PMID: 32499437     DOI: 10.1126/science.abb2559

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  3 in total

1.  Nickel-catalysed asymmetric hydrogenation of oximes.

Authors:  Bowen Li; Jianzhong Chen; Dan Liu; Ilya D Gridnev; Wanbin Zhang
Journal:  Nat Chem       Date:  2022-06-13       Impact factor: 24.274

2.  Asymmetric hydrogenation for the synthesis of 2-substituted chiral morpholines.

Authors:  Mingxu Li; Jian Zhang; Yashi Zou; Fengfan Zhou; Zhenfeng Zhang; Wanbin Zhang
Journal:  Chem Sci       Date:  2021-10-28       Impact factor: 9.825

Review 3.  Catalytic Reduction of Oximes to Hydroxylamines: Current Methods, Challenges and Opportunities.

Authors:  Josep Mas-Roselló; Nicolai Cramer
Journal:  Chemistry       Date:  2021-12-22       Impact factor: 5.020

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.